847
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Antiplasmodial Activity of Constituents Isolated from Croton lobatus.

, &
Pages 263-266 | Accepted 25 Sep 2006, Published online: 07 Oct 2008
 

Abstract

Seven constituents were isolated from the stems and leaves of Croton lobatus. L. (Euphorbiaceae), a medicinal plant used in western Africa in traditional folk medicine to cure malaria, pregnancy troubles, and dysentery. Their structures were elucidated by spectroscopic methods. The compounds identified were 3-[(6Z.,9Z.)dodeca-6,9-dienoyloxy]-2-octanoyloxypropyl(6Z.,9Z.)dodeca-6,9-dienoate (1) for the first time and six known compounds: (Z.,Z.,Z.)-9,12,15-octadecatrienoic acid methyl ester (2), 8,11,17,21-tetramethyl-(E.,E.,E.,E.)-8,10,17,21-tetraentetracosanoic acid (3), geranylgeraniol (4), cholestan-3-one (5), betulinic acid (6), and (E.)-3-(4-methoxy-phenyl)-2-phenyl-acrylic acid (7). From the seven compounds, (4) and (6) showed the best antiplasmodial activity in vitro. on Plasmodium falciparum. K1 chloroquine-resistant strain, with IC50 values (µg/mL) of 1.07 and 1.45 mg/mL, respectively, while compounds (2), (3), and (7) showed IC50 below 5 in the same assay. Cytotoxicity of the most active compounds was evaluated on L6 murine myoblast cells. Geranylgeraniol (4) showed good selectivity with an SI value (SI = ratio of cytotoxicity to biological activity) over 25.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.